Abstract
With the advent of new ultrasound contrastspecific scanning modes, the clinical potential of ultrasound contrast agents has been widely enhanced and the efficacy has been potentiated. Ultrasound contrast agents are based on microbubbles with a diameter of a few micrometers. Their efficacy was previously described mainly as echo enhancers for Doppler signals, and by enhancing the reflectivity of blood, the signal-to-noise ratio for Doppler signals can be enhanced and a clear Doppler trace may be obtained in otherwise difficult to scan patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agati L, Funaro S, Veneroso G, Volponi C, De Maio F, Madonna MP, Fedele F (2001) Non-invasive assessment of myocardial perfusion by intravenous contrast echocardiography: state of the art. Ital Heart J 2:403–437
Barnhart J, Levene H, Villapando E, et al (1990) Characteristics of Albunex, air-filled albumin microspheres for echocardiography. Invest Radiol 25:162–164
Basilico R, Blomley MJ, Harvey CJ, Filippone A, Heckemann RA, Eckersley RJ, Cosgrove DO. (2002) Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radiol 41:184–191
Bauer A, Blomley M, Leen E, Cosgrove D, Schlief R (1999 ) Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 9 Suppl 3:S349–352
Bogdahn U, Holscher T, Rosin L, Gotz B, Schlachetzki F (1999) Contrast enhanced transcranial and extracranial duplex sonography: preliminary results of a multicenter phase II/III study with SonoVuetrade mark. Echocardiography 16:761–766
Cohen JL, Cheirif J, Segar DS (1998) Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coli Cardiol 32:746–752
Dittrich HC, Bales GL, Kuvelas T (1995) Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J Am Soc Echocardiogr 8:465–474
Dhond MR, Nguyen TT, Dolan C, Pulido G, Bommer WJ (2000) Ultrasound-enhanced thrombolysis at 20 kHz with air-filled and pertluorocarbon-filled contrast biospheres. J Am Soc Echocardiogr 13:1025–1029
Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Invest Radiol 3:356–366
Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS (2000) Efficacy and safety of the novel trasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 86:669–674
Leen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB (2002) Multi-centre clinical study evaluating the efficacy of Sono Vue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41:200–206
Nanda NC, Wistran DC, Karlsberg RP, Hack TC, Smith WB, Foley DA, Picard MH, Cotter B (2002) Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography 19:27–36
Ophir J, Parker KJ (1989) Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15:319–333
Pelura TJ (1998) Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent. Acad Radiol 5 [Suppl 1]:S69–71
Rosenberg ML, Carpenter AP (2002) Contrast material-enhanced abdominal US examinations with DMP 115 (DEFINITY) provides additional diagnostic information with potential for changes in patient management. Acad Radiol 9 [Suppl 1]:S243–245
Schneider M (1999) Characteristics of SonoVue. Echocardiography 16:743–746
Schwarz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R (1994) A Study of the magnitude of Doppler enhancement with SH U 508 A in multiple vascular regions. Radiology 193:195–201
Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol U [Stippl 3]:E15–26
Unger E, Shen DK, Fritz T, Lund P, Wu GL, Kulik B, DeYoung D, Standen J, Ovitt T, Matsunaga T (1993) Gas-filled liposomes as echocardiographic contrast agents in rabbits with myocardial infarcts. Invest Radiol 28:1155–1159
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia
About this chapter
Cite this chapter
Bauer, A., Solbiati, L. (2003). Ultrasound Contrast Agents. In: Contrast-Enhanced Ultrasound of Liver Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-2093-1_2
Download citation
DOI: https://doi.org/10.1007/978-88-470-2093-1_2
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2168-6
Online ISBN: 978-88-470-2093-1
eBook Packages: Springer Book Archive